AstraZeneca PLC (NYSE:AZN)

50.80
Delayed Data
As of Jan 21
 -0.53 / -1.03%
Today’s Change
35.30
Today|||52-Week Range
51.55
+1.89%
Year-to-Date
AstraZeneca and Merck Get an FDA Priority Review for Lynparza in Prostate Cancer
Jan 21 / MotleyFool.com - Paid Partner Content
Here's Why Clovis Oncology Rose as Much as 25.6% Today
Jan 15 / MotleyFool.com - Paid Partner Content
2 Biotechs Battling Immune Diseases
Jan 19 / MotleyFool.com - Paid Partner Content
FDA Gives Clovis Oncology's Rubraca a Priority Review
Jan 15 / MotleyFool.com - Paid Partner Content
5 Reasons 2020 Will Be a Big Year for Ionis Pharmaceuticals
Jan 16 / MotleyFool.com - Paid Partner Content
Good News for Amarin: AstraZeneca Abandoning its Fish Oil Pill
Jan 13 / MotleyFool.com - Paid Partner Content
High Drug Prices Remains a Top Issue in Democratic Debates
Jan 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close51.33
Today’s open50.48
Day’s range50.48 - 51.04
Volume1,964,105
Average volume (3 months)3,005,916
Market cap$134.7B
Data as of 6:30pm ET, 01/21/2020

Growth & Valuation

Earnings growth (last year)-29.11%
Earnings growth (this year)+3.85%
Earnings growth (next 5 years)+18.93%
Revenue growth (last year)-2.88%
P/E ratio63.1
Price/Sales4.36
Price/Book10.43

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+1.33+0.95%
ABBVAbbVie-0.01-0.01%
SNYSanofi-1.03-2.01%
GSKGlaxoSmithKline-0.39-0.81%
Data as of 6:30pm ET, 01/21/2020

Financials

Next reporting dateFebruary 14, 2020
EPS forecast (this quarter)$0.50
Annual revenue (last year)$22.1B
Annual profit (last year)$2.2B
Net profit margin9.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Cambridge, Cambridgeshire

Forecasts